Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I FINK

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinomaM B Atkins, J Sparano, R I Fisher, et al.
Infectious Agents and Cancer|May 16, 2018
Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin AmericaValeria I Fink, Cathy A Jenkins, Jessica L Castilho, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 18, 2011
Cancer in HIV-infected persons from the Caribbean, Central and South AmericaValeria I Fink, Bryan E Shepherd, Carina Cesar, et al.
Plos One|June 10, 2010
Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin AmericaCarina Cesar, Bryan E Shepherd, Alejandro J Krolewiecki, et al.
HIV Medicine|December 18, 2020
The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naïve patients with HIV-infectionM I Figueroa, A Camiro-Zuñiga, P F Belaunzaran-Zamudio, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinomaM B Atkins, J Sparano, R I Fisher, et al.
Infectious Agents and Cancer|May 16, 2018
Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin AmericaValeria I Fink, Cathy A Jenkins, Jessica L Castilho, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 18, 2011
Cancer in HIV-infected persons from the Caribbean, Central and South AmericaValeria I Fink, Bryan E Shepherd, Carina Cesar, et al.
Plos One|June 10, 2010
Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin AmericaCarina Cesar, Bryan E Shepherd, Alejandro J Krolewiecki, et al.
HIV Medicine|December 18, 2020
The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naïve patients with HIV-infectionM I Figueroa, A Camiro-Zuñiga, P F Belaunzaran-Zamudio, et al.
Pageof 5